Diagnosis and Definition of Locally Advanced and Borderline Pancreas Cancer
暂无分享,去创建一个
T. Pawlik | R. Abrams | A. Koong | K. Goodman | W. Suh | J. Herman | S. Jabbour | P. Das | M. Abdel-Wahab | N. Azad | Percy Lee | A. Konski | Rachit Kumar | J. Hayes | J. Dragovic | W. Jones | J. Herman | P. Das
[1] T. Strom,et al. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma , 2015, Acta oncologica.
[2] Albert C. Koong,et al. Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma , 2014, Cancer.
[3] P. Mishra,et al. "Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer." , 2015, Annals of surgery.
[4] J. Cameron,et al. The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience , 2015, Annals of Surgical Oncology.
[5] Jeffrey W. Clark,et al. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. , 2014, International journal of radiation oncology, biology, physics.
[6] D. Goldstein,et al. Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study. , 2014 .
[7] David Goldstein,et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.
[8] E. Fishman,et al. Recent progress in pancreatic cancer , 2013, CA: a cancer journal for clinicians.
[9] Edward J. Kim,et al. A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer , 2013, Cancer.
[10] J. Berlin,et al. Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design , 2013, Annals of Surgical Oncology.
[11] D. Goldstein,et al. Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study. , 2013, Journal of Clinical Oncology.
[12] Daniel Normolle,et al. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. , 2012, International journal of radiation oncology, biology, physics.
[13] K. Behrns. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer , 2012 .
[14] David Cella,et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] T. Desser,et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. , 2011, International journal of radiation oncology, biology, physics.
[16] B. Agarwal,et al. Imaging of pancreatic cancer: An overview. , 2011, Journal of gastrointestinal oncology.
[17] B. B. Weitner,et al. Phase II trial of full-dose gemcitabine and bevacizumab in combination with attenuated three-dimensional conformal radiotherapy in patients with localized pancreatic cancer. , 2011, International journal of radiation oncology, biology, physics.
[18] M. Mino‐Kenudson,et al. Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. , 2011, International journal of radiation oncology, biology, physics.
[19] B. Yeap,et al. Phase I/II study of Proton-based Short Course Chemoradiation and Early Surgery for Adenocarcinoma of the Pancreas , 2010 .
[20] Tibor Schuster,et al. Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages , 2010, PLoS medicine.
[21] Alison P. Klein,et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] R. Semelka,et al. Magnetic Resonance Imaging of Adenocarcinoma of the Pancreas , 2009, Topics in magnetic resonance imaging : TMRI.
[23] B. Chauffert,et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] Jeffrey E. Lee,et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Jeffrey E. Lee,et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] K. Campbell,et al. Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer , 2008, Annals of Surgical Oncology.
[27] J. Berlin,et al. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Drebin. National Failure to Operate on Early Stage Pancreatic Cancer , 2008 .
[29] A. Ba-Ssalamah,et al. State-of-the-Art Magnetic Resonance Imaging of Pancreatic Cancer , 2007, Topics in magnetic resonance imaging : TMRI.
[30] Douglas B. Evans,et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy , 2007, Cancer.
[31] D. Tait,et al. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy , 2007, British Journal of Cancer.
[32] E. Touboul,et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] P. Philip,et al. A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma , 2006, Annals of Surgical Oncology.
[34] M. Gonen,et al. Long-Term Survival Is Superior After Resection for Cancer in High-Volume Centers , 2005, Annals of surgery.
[35] S. Lipsitz,et al. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. , 2005, International journal of radiation oncology, biology, physics.
[36] R. Labianca,et al. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] D. Tyler,et al. Neoadjuvant therapy for pancreatic cancer: the Duke experience. , 2004, Surgical oncology clinics of North America.
[38] Jeffrey W. Clark,et al. Long-term results of intraoperative electron beam irradiation for patients with unresectable pancreatic cancer , 2003 .
[39] Jeffrey E. Lee,et al. Abstracts reprinted from Journal of Clinical Oncology , 2002, Annals of Surgical Oncology.
[40] R. Talamini,et al. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. , 2001, International journal of radiation oncology, biology, physics.
[41] Jeffrey E. Lee,et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] James H. Stevens,et al. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] D. Neuberg,et al. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] T. Inoue,et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? , 1994, Archives of surgery.
[45] F. Ames,et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.
[46] Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. , 1988, Journal of the National Cancer Institute.
[47] P. Engstrom,et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] J. Barkin,et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.
[49] C. Moertel,et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.